Mammalian GMP Manufacturing
With its cutting-edge mammalian GMP manufacturing facilities, GTP Bioways is the ideal partner for the manufacturing of your proteins and monoclonal antibodies for clinical studies and small-batch commercial supply.
Expert mammalian GMP manufacturing services
Our services cover all steps from cell line development to cGMP manufacturing, through a strategic partnership with the Fareva group. Our facilities are perfectly sized to address your needs for clinical studies and small-batch commercial supply.
GTP Bioways benefits from the expertise of a technical team with over 15 years’ experience bringing antibodies and antibody-drugs conjugates to clinic.
With our in-house analytical QC capabilities and our seasoned QA team, we ensure a high and reproducible level of quality for all your productions.
Comprehensive CDMO services from discovery to clinic
GTP’s activities cover the full development cycle of your biotherapeutics, from supporting early-stage discovery through small-scale protein production to cGMP manufacturing.
GMP facility highlights
The innovative design of our state-of-the art facilities allows for capacity and technological flexibility, while ensuring compliance with the strict biopharmaceutical regulations required for cGMP operations.
Our production unit offers capacities ranging from 250L to 1000L, allowing for the production of up to kg batches.
The suites are equipped with single-use technologies to allow for the flexible production of your biologic with rapid turnaround times.
Rely on our GMP manufacturing expertise
We are proud to say that our manufacturing success rates exceed industry standards.
Top-notch fill and finish line
Our manufacturing offer is completed through in-house aseptic filling capacities, allowing us to shorten timelines for drug product supply.
Quality assurance & regulatory support
With over 15 years’ experience in mammalian GMP manufacturing of a range of biomolecules, the GTP Bioways team is uniquely placed to support your project.
Our QA team will work closely with our development and manufacturing teams to ensure the highest quality at every step.
Thanks to their longstanding experience of biotherapeutics development for pharmaceutical companies, our QA experts are familiar with IMPD/IND application filings and ready to assist you in the completion of these regulatory documents.
We offer customized solutions, contact us to discuss your project
GTP Bioways started providing custom recombinant protein production services in 2000 to accelerate biopharmaceutical development and overcome a wide range of challenges.
